Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 1626

1.

Violence against women and cervical cancer screening: a systematic review.

Leite FM, Amorim MH, Primo CC, Gigante DP.

J Clin Nurs. 2016 May 16. doi: 10.1111/jocn.13328. [Epub ahead of print] Review.

PMID:
27195898
2.

[Is the PAP smear era coming to an end?].

Nowak-Markwitz E, Spaczyński M.

Ginekol Pol. 2015 Dec;86(12):947-50. Review. Polish.

PMID:
26995946
3.

Screening for Chlamydia is acceptable and feasible during Cervical Screening in General Practice.

Hassan SJ, Dunphy E, Navin E, Marron L, Fitzsimmons C, Loy A, O'Shea B.

Ir Med J. 2016 Jan;109(1):326-7.

PMID:
26904785
4.

Atypical glandular cells on cervical cytology.

Mayrand MH, Koushik A.

BMJ. 2016 Feb 11;352:i723. doi: 10.1136/bmj.i723. No abstract available.

PMID:
26869616
5.

Risk of invasive cervical cancer after atypical glandular cells in cervical screening: nationwide cohort study.

Wang J, Andrae B, Sundström K, Ström P, Ploner A, Elfström KM, Arnheim-Dahlström L, Dillner J, Sparén P.

BMJ. 2016 Feb 11;352:i276. doi: 10.1136/bmj.i276.

6.

ETHICAL AND DEMOGRAPHICAL ISSUES IN SCREENING FOR CERVICAL CANCER--AN OUTLINE IN NORTH EASTERN REGION OF ROMANIA.

Chelaru L, Amihaesei CI, Trandafirescu MF, Matei Mioara Calipsoara, Manole A.

Rev Med Chir Soc Med Nat Iasi. 2015 Oct-Dec;119(4):1113-9.

PMID:
26793857
7.

Cervical cancer control in Latin America: A call to action.

Bychkovsky BL, Ferreyra ME, Strasser-Weippl K, Herold CI, de Lima Lopes G Jr, Dizon DS, Schmeler KM, Del Carmen M, Randall TC, Nogueira-Rodrigues A, de Carvalho Calabrich AF, St Louis J, Vail CM, Goss PE.

Cancer. 2016 Feb 15;122(4):502-14. doi: 10.1002/cncr.29813. Epub 2015 Dec 15. Review.

PMID:
26670695
8.

Assessing Cervical Cancer Screening Coverage Using a Population-Based Behavioral Risk Factor Survey--Thailand, 2010.

Joseph R, Manosoontorn S, Petcharoen N, Sangrajrang S, Senkomago V, Saraiya M.

J Womens Health (Larchmt). 2015 Dec;24(12):966-8. doi: 10.1089/jwh.2015.5624.

PMID:
26653868
9.

Costs and Cost Effectiveness of Three Approaches for Cervical Cancer Screening among HIV-Positive Women in Johannesburg, South Africa.

Lince-Deroche N, Phiri J, Michelow P, Smith JS, Firnhaber C.

PLoS One. 2015 Nov 16;10(11):e0141969. doi: 10.1371/journal.pone.0141969. eCollection 2015.

10.

Feasibility and accuracy evaluation of three human papillomavirus assays for FTA card-based sampling: a pilot study in cervical cancer screening.

Wang SM, Hu SY, Chen W, Chen F, Zhao FH, He W, Ma XM, Zhang YQ, Wang J, Sivasubramaniam P, Qiao YL.

BMC Cancer. 2015 Nov 4;15:848. doi: 10.1186/s12885-015-1882-9.

11.

HPV testing alone is not as safe as cytology and selective HPV testing: FOR: The sensitivity of HPV testing is not high enough.

Dudding N.

BJOG. 2016 Jan;123(1):68. doi: 10.1111/1471-0528.13637. Epub 2015 Nov 3. No abstract available.

PMID:
26527310
12.

[Prevalence of non-vaccinable high risk genotypes of human papillomavirus in the Early Detection of Cervical Cancer Program in Cantabria].

Paz-Zulueta M, Fernández-Feito A, Amparán Ruiz M, Azofra Olave A, Martín Seco Y, Ojugas Zabala S, Otero García A, Royano Rasines C, Sarabia-Lavín R, Torres Manrique B, Santibáñez Margüello M.

Aten Primaria. 2016 Jun-Jul;48(6):347-55. doi: 10.1016/j.aprim.2015.07.006. Epub 2015 Oct 29. Spanish.

13.

The paradigm shift in cervical cancer screening in Germany.

Hillemanns P.

Arch Gynecol Obstet. 2016 Jan;293(1):3-4. doi: 10.1007/s00404-015-3940-6. Epub 2015 Oct 29.

PMID:
26514679
14.

Cervical Cancer Screening in an Early Diagnosis and Screening Center in Mersin, Turkey.

Nayir T, Okyay RA, Nazlican E, Yesilyurt H, Akbaba M, Ilhan B, Kemik A.

Asian Pac J Cancer Prev. 2015;16(16):6909-12.

15.

Expression of p16/Ki-67 in ASC-US/LSIL or Normal Cytology with Presence of Oncogenic HPV DNA.

Solares C, Velasco J, Álvarez-Ruiz E, González-Fernández L, Encinas AI, Astudillo A, Schneider J.

Anticancer Res. 2015 Nov;35(11):6291-5.

PMID:
26504065
16.

How group education impacts female factory workers' behavior and readiness to receive mammography and Pap smear.

Seven M, Bahar M, Akyüz A, Erdoğan H.

Work. 2015;52(1):195-201. doi: 10.3233/WOR-152041.

PMID:
26410234
17.

Historical Analysis of the Brazilian Cervical Cancer Screening Program from 2006 to 2013: A Time for Reflection.

Costa RF, Longatto-Filho A, Pinheiro C, Zeferino LC, Fregnani JH.

PLoS One. 2015 Sep 24;10(9):e0138945. doi: 10.1371/journal.pone.0138945. eCollection 2015.

18.

Prevention, diagnosis and treatment of cervical cancer precursor lesions at the Xingu Indigenous Park, Brazil.

Pereira ER, Speck NM, Rodrigues DA, De Freitas VG, Ribalta JC.

Eur J Gynaecol Oncol. 2015;36(4):376-82.

PMID:
26390686
19.

Cervical cytology and the diagnosis of cervical cancer in older women.

Landy R, Castanon A, Dudding N, Lim AW, Hollingworth A, Hamilton W, Sasieni PD.

J Med Screen. 2015 Dec;22(4):207-12. doi: 10.1177/0969141315598174. Epub 2015 Sep 7.

20.

Accuracy of Combined Visual Inspection with Acetic Acid and Cervical Cytology Testing as a Primary Screening Tool for Cervical Cancer: a Systematic Review and Meta-Analysis.

Chanthavilay P, Mayxay M, Phongsavan K, Marsden DE, White LJ, Moore L, Reinharz D.

Asian Pac J Cancer Prev. 2015;16(14):5889-97. Review.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk